Nvidia Partners with Eli Lilly to Invest $1 Billion in AI Drug Development Lab
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 12 2026
0mins
Should l Buy ?
Source: aastocks
Nvidia's Investment: Nvidia announced a $1 billion investment over five years in partnership with Eli Lilly to create a new laboratory focused on AI applications in the pharmaceutical industry.
Location and Purpose: The new facility will be situated in Silicon Valley, aiming to integrate Eli Lilly's laboratory technology with Nvidia's AI innovation efforts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
